Pelago, formerly Quit Genius, is the world’s leading virtual clinic for substance use management. It helps its users tackle addictions to tobacco, opioids, and alcohol. It is the world’s first real-time personalised and gamified cognitive behavioural therapy (CBT) delivered over a smartphone that uses an evidence-based program designed to engage and set each member up for a successful quit attempt.

Pelago provides personalised substance abuse treatment and training for employees that can help reduce healthcare spend. The company is active in the UK and the USA, with over 30,000 people having successfully quite their substance abuse habits using Pelago.

Over 30,000 people have successfully quit their substance abuse habits using Pelago. The company is also beta testing its program for vaping, with programs for alcohol and substance use currently in development.

Pelago has been validated in 6 peer-reviewed studies and has been featured in Forbes, TechCrunch, the British Thoracic Society, MailOnline, the European Medical Journal, WIRED and many more publications.

Pelago now partners with health plans and utilises a data-driven approach to enrolment marketing. This enrolment strategy drives up to 11x greater enrolment for the tobacco cessation program and 5x greater enrolment for the alcohol program.